DCGI nod to Covaxin for use in children above 12 years with certain conditions

NEW DELHI: The Drugs Controller General of India (

DCGI

) has granted emergency use authorisation to Bharat Biotech's Covaxin for children above 12 years with certain conditions, sources said on Saturday.

The

Subject Expert Committee

on Covid-19 of the CDSCO on October 12 after deliberating Bharat Biotech's

EUA

application had recommended granting emergency use approval to Covaxin for use in the 12-18 years age group with certain conditions.

"The recommendations of the

SEC

were evaluated by another experts committee after which DCGI had sought additional data from the firm," a source said.

The DCGI gave its approval Friday, the source said.